OmniaManufacturing Services for Novel Biologics

Cells
About the images

Company Profile

Omnia offers an array of manufacturing and process development services for companies engaged in the development of novel biologics. Our experience in many of these areas – from preclinical gene therapeutics through commercial recombinant proteins – gives Omnia a unique and specialized approach for developing manufacturing processes.

The company has both non-GMP and GMP facilities for process development through Phase I/II manufacture.


Technical Focus
:
 
- Adenovirus
- Lentivirus
- Retrovirus
- AAV
- VLP
- Other viral platforms 

Contact us to meet at our scheduled
conferences and tradeshows:
- BIO 2013 World Congress (Montreal, Quebec, June 16-19, 2013)
- Cancer Vaccines & Gene Therapy (Malvern, PA, October 3-4, 2013)
- 2nd International Conference and Exhibition on Cell & Gene Therapy (Orlando, Fl, October 23-25, 2013)